Our mission is to create connections, so people can learn from the experience of others and gain the inspiration to live a fuller life. We support special events and scholarship opportunities. "Like" us to get all the updates and help spread the word.
Changing Hemophilia® is proudly sponsored by Novo Nordisk Inc.
We’d like to be clear, direct, and up front about the restrictions within which the Changing Hemophilia® page must operate.
The Changing Hemophilia® page exists to bring together the community of people, from patients to caregivers to friends and relations, whose lives are affected by hemophilia, and to offer support and education through that community. Because the page is sponsored and owned by Novo Nordisk, a pharmaceutical company, it is governed by FDA regulations and other federal laws.
While it is the goal of the Changing Hemophilia® page to foster open communication and a candid exchange of ideas, stories, and sentiments, there is simply some content we are restricted from publishing, or allowing to be published, on the page. It is not our intention to censor our community members in any way; however, we must operate within the rules.
The following Commenting Guidelines explain the restrictions of this page. Thank you for your understanding and for ensuring that your comments fit within these guidelines. While Novo Nordisk reserves the right to remove any posting at its sole discretion, we are working to foster communication and candor; in this spirit, we will only remove comments that violate these guidelines. Please contact us via private message with any questions or concerns.
1. Product Mention. Please don’t reference the products of any pharmaceutical company, whether positively or negatively. Important regulations govern exactly what can be said about products within the context of this page—it’s better to just leave them out of the conversation.
2. Side Effects. Facebook is not the appropriate forum for reporting side effects of prescription drugs. So that we can best deal with the information, please report side effects to us by calling 1-800-727-6500, or directly to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
3. Links and Tags. While we do not endorse any page content other than our own, we must take care that all of it—including links to other pages and tags to other pages—is within the regulations that govern our page. Because we can’t take responsibility for the content on other websites, please do not post any links or tags on this page.
4. Vulgarity or Personal Attacks. The Changing Hemophilia® page is a community for all, without discrimination on the basis of ethnicity, race, religious affiliation, age, or gender orientation. It is a place of respect. We prohibit comments containing profanity or any hostile, harassing, or discriminatory language.
5. Medical Advice. While we appreciate the community’s desire to help one another, and while we encourage sharing experiences, please leave the dispensing of medical advice to the medical professionals—and even if you are a medical professional, please leave it to an individual’s health care practitioner. Medical advice can have serious implications. We are all different, with different health histories and concerns. A treatment that worked for you or someone you know won’t necessarily work for someone else. In the interest of keeping everyone safe, please don’t post specific information about treatments, techniques, therapies, medications, etc.
6. Off Topic. We’d like the Changing Hemophilia® page to be a forum for conversation and for sharing experiences, and in that regard, this is a nebulous area; however, comments occasionally arise that are clearly unrelated to the topic, or are spam, or are promotions for goods or services. These comments are not allowed on the page.
7. Miscellaneous. In the event that a comment does not fit into one of these categories but nonetheless is not suitable for the Changing Hemophilia® page, Novo Nordisk reserves the right to remove any posting at its sole discretion.
